Amanda Lisher

DOS 731: Research II

Citation Assignment
July 12, 2015
References
1. Mehta N, King CR, Agazaryan N, et al. Stereotactic body radiotherapy and 3-dimensional
conformal radiotherapy for stage I non-small cell lung cancer: a pooled analysis of biological
equivalent dose and local control. Pract Radiat Oncol. 2012;2(4):288-295.
http://dx.doi.org/10.1016/j.prro.2011.10.004
2. Dunlap NE, Cai JC, Biedermann GB, et al. Chest wall volume receiving >30 Gy predicts risk
of severe pain and/or rib fracture after lung stereotactic body radiotherapy. Int J Radiat
Oncol Biol Phys. 2010;76(3):796-801. http://dx.doi.org/10.1016/j.ijrobp.2009.02.027
3. Bogart JA, Hodgson L, Seagren SL, et al. Phase I study of accelerated conformal
radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction:
CALGB 39904. J Clin Oncol. 2010;28(2):202-206.
http://dx.doi.org/10.1200/JCO.2009.25.0753
4. Woody NM, Videtic GMM, Stephans KL, et al. Predicting chest wall pain from lung
stereotactic body radiotherapy for different fractionation schemes. Int J Radiat Oncol Biol
Phys. 2012;83(1):427-434. http://dx.doi.org/10.1016/j.ijrobp.2011.06.1971
5. Fowler JF. 21 years of biologically effective dose. Br J Radiol. 2010;83(991):554-568.
http://dx.doi.org/10.1259/bjr/31372149